These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8445490)

  • 1. AgNOR counts have no prognostic value in breast cancer.
    Toikkanen S; Joensuu H
    J Pathol; 1993 Feb; 169(2):251-4. PubMed ID: 8445490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silver-stained nucleolar organiser region counts are of no prognostic value in primary breast cancer.
    Sacks NP; Robertson JF; Ellis IO; Nicholson RI; Crocker J; Blamey RW
    Eur J Surg Oncol; 1992 Apr; 18(2):98-102. PubMed ID: 1582518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silver-binding nucleolar organizer regions (AgNORs) in benign and malignant breast lesions: correlations with ploidy and growth phase by DNA flow cytometry.
    Giri DD; Nottingham JF; Lawry J; Dundas SA; Underwood JC
    J Pathol; 1989 Apr; 157(4):307-13. PubMed ID: 2715879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic value of AgNORs in breast cancer].
    Aubele M; Auer G; Jütting U
    Zentralbl Pathol; 1994 Mar; 140(1):55-60. PubMed ID: 7515674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AgNORs in ductal breast cancer: correlation with ploidy and S-phase fraction by DNA flow cytometry.
    Borgiani L; Cogorno P; Oliviero J; Toso F; Gambini G; Tunesi G; Canepa M
    Eur J Histochem; 1994; 38(2):171-6. PubMed ID: 7524814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of argyrophylic nucleolar organiser regions (AgNORs) in breast lesions.
    Simha M; Menon M; Doctor V
    Indian J Cancer; 1996 Jun; 33(2):76-85. PubMed ID: 8979469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic relevance of silver stained nucleolar organizer region (AgNORs) in benign and malignant breast lesions.
    Agarwal PK; Mehrotra A; Chandra T
    Indian J Exp Biol; 1995 Oct; 33(10):715-20. PubMed ID: 8575800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Argyrophilic nucleolar organizer regions in breast cancer: prognostic significance.
    Kolár Z; Zábranský T; Mattler K; Zábranský E
    Cesk Patol; 1992 Sep; 28(4):193-200. PubMed ID: 1335841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Argyrophilic nucleolar organizer region (AgNOR) counting in astrocytic gliomas: prognostic value.
    Ferreres JC; Figols J; Val-Bernal JF; Cardesa A; Cruz Sánchez FF
    Histol Histopathol; 1996 Jan; 11(1):35-9. PubMed ID: 8720446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Silver-stained Nucleolar Organizer Regions (AgNOR)].
    Derenzini M; Trerè D
    Pathologica; 2001 Apr; 93(2):99-105. PubMed ID: 11428299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of argyrophilic nucleolar organizer regions (AGNOR) in oesophageal cancer.
    Babu M; Mathur M; Gupta SD; Chattopadhyay TK
    Trop Gastroenterol; 1996; 17(1):57-60. PubMed ID: 8693588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical significance of argyrophilic nucleolar organizer regions (AgNOR) and microvessel quantitation by staining for factor VIII-related antigen as prognostic indicators in stage I breast cancer].
    Ogawa Y; Chung YS; Nakata B; Takatsuka S; Maeda K; Sawada T; Kato Y; Yoshikawa K; Sowa M
    Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():66-70. PubMed ID: 7747994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleolar organizer regions (AgNORs) in in situ and invasive components of breast cancers.
    Răşinaru A; Olinici CD; Blaga ML
    Rom J Morphol Embryol; 1994; 40(1-2):7-10. PubMed ID: 7640380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleolar organizer regions in human breast cancer.
    Roller E; Fritz P; Wicherek C; Klumpp B; Lauinger J; Mischlinski A; Wanner B; Schumacher K
    Zentralbl Pathol; 1993 Aug; 139(3):195-9. PubMed ID: 8218120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleolus organizer regions (AgNORs) in ductal mammary carcinoma. Comparison with classifications and prognosis.
    Aubele M; Auer G; Gais P; Jütting U; Rodenacker K; Voss A
    Pathol Res Pract; 1994 Feb; 190(2):129-37. PubMed ID: 7520163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silver-stained nucleolar organizer regions in normal and dysplastic cervical lesions: correlation with DNA ploidy and S-phase fraction by flow cytometry.
    Singh M; Prasad S; Kalra N; Singh U; Shukla Y
    Oncology; 2006; 71(5-6):411-6. PubMed ID: 17785995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Counting the nucleolar organizer region-associated proteins is a prognostic clue of malignant melanoma.
    Gambini C; Casazza S; Borgiani L; Canepa M; Rovida S; Rongioletti F; Rebora A
    Arch Dermatol; 1992 Apr; 128(4):487-90. PubMed ID: 1580655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleolar organizer regions in smooth muscle and breast tumours.
    Reddy GS; Sesikeran B; Bhaskaran CS
    Indian J Pathol Microbiol; 1992 Jul; 35(3):219-28. PubMed ID: 1344157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of significance of AgNOR counts in differentiating benign from malignant lesions in the breast.
    Dube MK; Govil A
    Indian J Pathol Microbiol; 1995 Jan; 38(1):5-10. PubMed ID: 8919463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of the AgNOR parameter in human breast cancer depends on the pRb and p53 status.
    Derenzini M; Ceccarelli C; Santini D; Taffurelli M; Treré D
    J Clin Pathol; 2004 Jul; 57(7):755-61. PubMed ID: 15220371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.